Using washed microbiota transplantation to treat Tourette's syndrome
Official title: Efficacy and Safety of Washed Microbiota Transplantation for Tourette's Syndrome
Run by The Second Hospital of Nanjing Medical University · NCT03764748 · Data updated 2026-11-12
This study is testing whether a new treatment that involves transferring healthy gut bacteria can help people with Tourette's syndrome feel better.
Quick facts
| Phase | Phase 1 |
|---|---|
| Study type | Interventional |
| Ages | 6 Years to 17 Years |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | The Second Hospital of Nanjing Medical University Academic / other |
| Locations | 2 sites (Nanjing, Jiangsu and 1 other locations) |
| Status | Recruiting |
| Started | April 17, 2024 |
| Main results expected | October 31, 2027 |
| Study ends | October 31, 2027 |
| Registry record updated | August 19, 2024 |
| Trial ID | NCT03764748 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates for this study are children and adolescents aged 6 to 17 who have been diagnosed with Tourette's syndrome and have a significant level of tic severity.
✕Probably not a fit
Patients with other severe neurological or psychiatric disorders, or those whose symptoms are primarily due to conditions like autism or obsessive-compulsive disorder, may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the efficacy of washed microbiota transplantation (WMT) as a treatment for Tourette's syndrome (TS). It is based on emerging evidence that gut microbiota can influence the central nervous system, suggesting that restoring gut microbiota may help alleviate TS symptoms. The study involves transferring gut microbiota from healthy donors to patients using a specialized washing process to enhance the treatment's effectiveness. Participants will be assessed using standardized questionnaires to measure the impact of WMT on TS and its comorbidities.
Why it matters
Potential benefit: If successful, this treatment could significantly improve the quality of life for patients with Tourette's syndrome by reducing tic severity.
How similar studies have gone: While the approach of using microbiota transplantation is gaining traction in treating gut-brain axis-related disorders, this specific application for Tourette's syndrome is novel and has not been extensively tested in prior studies.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. Patients were aged 6 to 17 years (inclusive); 2. Met the Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition criteria for TS; 3. Had a Yale Global Tic Severity Scale-Total Tic Score (YGTSS-TTS) of at least 20 at screening and baseline. 4. Underwent WMT. Exclusion Criteria: 1. Complicated with certain brain disease, including tumor,injury,cerebrovascular disease; 2. Complicated with other severe disease, including cancers, organ failure, heart diseases; 3. Stereotypy associated with autism spectrum disorder; 4. With a confirmed diagnosis of psychiatric diseases, such as bipolar disorders; schizophrenia and major depressive disorders; 5. Clinically significant obsessive-compulsive disorder at baseline considered to be the primary cause of impairment at baseline; 6. Medications use affecting gut microbiota such as antibiotics and probiotics three months before WMT. 7. Other neurologic disorders other than TS that could influence the evaluation of tics.
Where it's running
-
Department of Microbiota Medicine & Medical Centre for Digestive Diseases, The Second Affiliated Hospital of Nanjing Medical University
Nanjing, Jiangsu, China Recruiting -
SIR RUN RUN hospital of Nanjing Medical University
Nanjing, Jiangsu, China Recruiting
Study contacts
- Study coordinator: Faming Zhang, MD; PHD
- Email: fzhang@njmu.edu.cn
- Phone: 025-58509883
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Nature- and activity-based group programs for neurodivergent children and youth in Agder
This project will try outdoor and activity-based group programs to see if they help children and teens with ADHD, autism, Tourette's, and related neurodivergent challenges feel better, gain confidence, and do better in daily life.
-
Study of brain activity in patients with Tourette Syndrome
This study is testing how brain activity changes in adults with severe Tourette Syndrome who are getting deep brain stimulation to better understand their tics.
-
Personalized deep brain stimulation for Tourette syndrome
This study is testing if personalized deep brain stimulation can help people with Tourette syndrome reduce their tics and improve related issues like anxiety and attention problems.
-
Cognitive-psychophysiological therapy, with or without biofeedback, for tics in young people with Tourette's
This project tests whether adding biofeedback to cognitive-psychophysiological therapy helps reduce tics in 14–21-year-olds with Tourette's.
-
Personalized neurostimulation for Tourette's Syndrome
This study is testing a personalized brain stimulation treatment for adults with Tourette's Syndrome who haven't found relief from other therapies to see if it can help reduce their severe tics.
-
Understanding changes in Tourette Syndrome
This study is trying to learn how Tourette Syndrome and tic disorders change over time in kids by using new technology to track their symptoms.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.